The researchers examined 40 patients who underwent ACDF for adjacent segment disease. The researchers found:
1. The patients undergoing ACDF for adjacent segment disease reported significant improvement in the NRS-NP, NRS-AP, NDI, SF-12 PCS and ZDS outcomes measures.
2. The patient-reported health states also improved. The patients reported an average two-year gain of 0.54 quality-adjusted life year.
3. The average cost of surgery was $32,616. The average direct costs were $25,391 while the average indirect cost was $7,225.
4. The procedure was associated with average two-year cost per QALY gained of around $69,526.
5. The study authors concluded the procedure was cost effective.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.